108 related articles for article (PubMed ID: 139447)
1. Human immunodeficiency disease: impairment of cellular interactions leading to abnormal mediator production in mixed lymphocyte culture reaction.
Gorski AJ; Dupont B; Hansen JA; Safai B; Pahwa S; Good RA
J Immunol; 1977 Mar; 118(3):858-62. PubMed ID: 139447
[TBL] [Abstract][Full Text] [Related]
2. Leukocyte migration inhibitory factor (LMIF) profile in primary and secondary immunodeficiency disease.
Górski AJ; Dupont B; Hansen JA; O'Reilly R; Smithwick E; Górska R; Good RA
Clin Exp Immunol; 1976 Dec; 26(3):505-10. PubMed ID: 795576
[TBL] [Abstract][Full Text] [Related]
3. Leukocyte migration inhibitory factor (LMIF) production in unidirectional mixed lymphocyte cultures.
Górski AJ; Dupont B; Hansen JA; Good RA
J Immunol; 1976 Sep; 117(3):865-70. PubMed ID: 134123
[TBL] [Abstract][Full Text] [Related]
4. Spontaneous release of leukocyte migration inhibition factor (LMIF) by lymphocytes in chronic lymphatic leukemia patients.
Crivii SM; Crişan M; Crişan M
Arch Geschwulstforsch; 1984; 54(1):85-9. PubMed ID: 6367694
[TBL] [Abstract][Full Text] [Related]
5. Mixed lymphocyte culture stimulatory and responding capacity of lymphocytes from patients with lymphoproliferative diseases.
Rühl H; Vogt W; Bochert G; Schmidt S; Moelle R; Schaoua H
Clin Exp Immunol; 1975 Jan; 19(1):55-65. PubMed ID: 128426
[TBL] [Abstract][Full Text] [Related]
6. MLC stimulatory capacity and production of blastogenic factor in patients with chronic lymphatic leukemia and Hodgkin's disease.
Kasakura S
Blood; 1975 Jun; 45(6):823-32. PubMed ID: 123801
[TBL] [Abstract][Full Text] [Related]
7. Human T-cell heterogeneity as delineated with a specific human thymus lymphocyte antiserum. In vitro effects on mitogen response mixed leukocyte culture, cell-mediated lymphocytotoxicity, and lymphokine production.
Woody JN; Ahmed A; Knudsen RC; Strong DM; Sell KW
J Clin Invest; 1975 May; 55(5):956-66. PubMed ID: 1091657
[TBL] [Abstract][Full Text] [Related]
8. Spontaneous production of an inhibitor in vitro lymphocyte migration by lymphocytes from patients with Hodgkin's disease and mycosis fungoides.
Skopińska-Rónzewska E; Zółtowska A; Dziewulska-Bokiniec A
Arch Immunol Ther Exp (Warsz); 1982; 30(1-2):57-62. PubMed ID: 6756337
[No Abstract] [Full Text] [Related]
9. Rosette formation with mouse erythrocytes. III. Studies in patients with primary immunodeficiency and lymphoproliferative disorders.
Gupta S; Good RA; Siegal FP
Clin Exp Immunol; 1976 Nov; 26(2):204-13. PubMed ID: 1068759
[TBL] [Abstract][Full Text] [Related]
10. Lymphocyte function in patients with Hodgkin's disease.
Rühl H; Vogt W; Rühl U
G Batteriol Virol Immunol; 1975; 68(1-6):3-16. PubMed ID: 128484
[TBL] [Abstract][Full Text] [Related]
11. Impaired cellular interactions involving lymphocytes from patients with chronic lymphocytic leukemia and ataxia-telangiectasia.
Weisbart RH; Kacena A; Golde DW; Costea NV
J Lab Clin Med; 1980 Jul; 96(1):114-8. PubMed ID: 6993592
[TBL] [Abstract][Full Text] [Related]
12. [Clinical significance of lymphocyte populations].
Flad HD
Med Klin; 1979 Aug; 74(34):1199-206. PubMed ID: 388169
[No Abstract] [Full Text] [Related]
13. Characterization of the alloactivated E+Ia+ cell capable of stimulating in mixed lymphocyte culture.
Shen HH; Irigoyen O; Friedman SM; Chess L
J Immunol; 1982 Jan; 128(1):501-5. PubMed ID: 6459379
[TBL] [Abstract][Full Text] [Related]
14. Hodgkin's disease. An immunodepleting and immunosuppressive disorder.
Twomey JJ; Laughter AH; Farrow S; Douglass CC
J Clin Invest; 1975 Aug; 56(2):467-75. PubMed ID: 125290
[TBL] [Abstract][Full Text] [Related]
15. Cellular and genetic restrictions in the immunoregulatory activity of alpha-fetoprotein. III. Role of the MLC-stimulating cell population in alpha-fetoprotein-induced suppression of T cell-mediated cytotoxicity.
Peck AB; Murgita RA; Wigzell H
J Immunol; 1982 Mar; 128(3):1134-40. PubMed ID: 6173421
[TBL] [Abstract][Full Text] [Related]
16. Immunological capacity of lymphocytes from untreated patients with Hodgkin's disease evaluated in mixed lymphocyte culture.
Björkholm M; Holm G; Mellstedt H; Pettersson D
Clin Exp Immunol; 1975 Dec; 22(3):373-7. PubMed ID: 131665
[TBL] [Abstract][Full Text] [Related]
17. [Autologous mixed lymphocyte culture (AMLC)].
Volk HD; Grunow R
Allerg Immunol (Leipz); 1984; 30(2):60-73. PubMed ID: 6237558
[TBL] [Abstract][Full Text] [Related]
18. Impaired cell-mediated immunity in Hodgkin's disease mediated by suppressor lymphocytes and monocytes.
Hillinger SM; Herzig GP
J Clin Invest; 1978 Jun; 61(6):1620-7. PubMed ID: 149140
[TBL] [Abstract][Full Text] [Related]
19. Human T lymphocytes grown in T-cell growth factor: functional attributes in MLC, CML, PLT and allogeneic suppression.
Pawelec G; Rehbein A; Müller C; Sonneborn HH; Wernet P
Immunology; 1981 Apr; 42(4):529-40. PubMed ID: 6453828
[TBL] [Abstract][Full Text] [Related]
20. Role of monocytes, alloantigens, and individual reactivity in the response of human lymphocytes to mitogenic factor.
Ruiz P; Scornik JC
J Immunol; 1982 Mar; 128(3):1289-95. PubMed ID: 6460059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
